1. Home
  2. GLYC

GLYC

GlycoMimetics Inc.

Logo GlycoMimetics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Founded: 2003 Country:
United States
United States
Employees: N/A City: ROCKVILLE
Market Cap: 166.9M IPO Year: 2014
Target Price: $10.00 AVG Volume (30 days): 384.4K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.58 EPS Growth: N/A
52 Week Low/High: $1.11 - $3.53 Next Earning Date: 05-01-2024
Revenue: $10,000 Revenue Growth: -86.67%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: